Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: an immunohistochemical study

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 107, Issue 1, 2009, Pages 22-29

  Alam, Shamiul ^a   Ueki, Koichiro ^a   Nakagawa, Kiyomasa ^a   Marukawa, Kohei ^a   Hashiba, Yukari ^a   Yamamoto, Etsuhide ^a   Sakulsak, Natthiya ^a   Iseki, Shoichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATELOCOLLAGEN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KI 67 ANTIGEN; PRAVASTATIN; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BIOSYNTHESIS; BONE REGENERATION; DRUG EFFECT; ENZYME IMMUNOASSAY; HUMAN; MALE; NASAL BONE; RABBIT;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; COLLAGEN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; NASAL BONE; PRAVASTATIN; RABBITS; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 57649166552     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2008.06.025     Document Type: Article

References (24)

1. Henwood J.M., and Heel R.C. Lovastatin. A preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidemia. Drugs 36 (1988) 429-454
2. Kishida Y., Naito A., Iwado S., Terahara A., and Tsujita Y. Research and development of pravastatin. Yakugaku Zasshi 111 (1991) 469-487
3. Todd P.A. Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolemia. Goaki. Drugs 40 (1990) 583-607
4. Hunninghake D.B. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy. Am J Med 104 (1998) 9s-13s
5. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., et al. Stimulation of bone formation in vitro and in rodents by statins. Science 286 (1999) 1946-1949
6. Wozeny J.M., Rosen V., Celestre A.J., Mitsok L.M., Whitters M.J., Kriz R.W., et al. Novel regulators of bone formation: molecular clones and activities. Science 242 (1988) 1528-1534
7. Ueki K., Takazakura D., Marukawa K., Shimada M., Nakagawa K., Takatsuka S., et al. The use of polylactic acid/ polyglycolic acid copolymer and gelatin sponge complex containing human recombinant bone morphogenetic protein-2 following condylectomy in rabbits. J Craniomaxillofac Surg 31 (2003) 107-114
8. Kusumoto K., Bessho K., Fujimura K., Ogawa Y., and Iizuka T. Intermuscular osteoinduction and bone marrow formation by the implantation of rh-BMP-2 with atelopeptide type I collagen. Br J Oral Maxillofacial Surg 35 (1997) 433-437
9. Schmitz J.P., and Hollinger J.O. The critical size defect as an experimental model for cranio-mandibulofacial nonunions. Clin Orthop 205 (1986) 299-308
10. Rogers M.J. Statins: lower lipid and better bones. Nat Med 6 (2000) 21-23
11. Wong R.W., and Rabie A.B. Histological and ultrastructural study on statin graft in rabbit skulls. J Oral Maxillofacial Surg 63 (2005) 1515-1521
12. Bellows C.G., Aubin J.E., Heersche J.N., and Antosz M.E. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 38 (1986) 143-154
13. Maniatopoulos C., Melcher A.H., and Sodek J. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 254 (1988) 317-330
14. Marie P.J. Human endosteal osteoblastic cells: relationship with bone formation. Calcif Tissue Int 56 (1995) 13-16
15. Mizutani H., and Urist M.R. The nature of bone morphogenetic protein (BMP) fractions derived from bovine bone matrix gelatin. Clin Orthop Res 171 (1982) 213-223
16. Alam S., Ueki K., Marukawa K., Ohara T., Hase T., Takazakura D., et al. Expression of bone morphogenetic protein-2 and fibroblast growth factor-2 during bone regeneration using different implant materials as an on lay bone graft in rabbit mandibles. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 (2007) 16-26
17. Fujimura K., Bessho K., Kusumoto K., Ogawa Y., and Iizuka T. Experimental studies on bone inducing activity of composites atelopeptide type 1 collagen as a carrier for ectopic osteoinduction by rh-BMP-2. Biochem Biophys Res Commun 208 (1995) 316-322
18. Inoda H., Yamamoto G., and Hattory T. Histological investigation of osteoinductive properties of the rh-BMP-2 in rat calvarial bone defect model. J Craniomaxillofac Surg 32 (2004) 365-369
19. Omura S., Mizuki N., Kawabe R., Ota S., Kobayashi S., and Fujita K. A carrier for clinical use of rh-BMP-2 dehydrothermally cross linked composite of fibrillar and denatured atelo-collagen sponge. Int J Oral Maxillofac Surg 27 (1998) 129-134
20. Carl A.K. Potential applications and delivery strategies for bone morphogenetic proteins. Adv Drug Deliv Rev 43 (2000) 65-92
21. Nagi N., Qin C.L., Nagatsuka H., Inoue M., and Ishiwari Y. Age effects on ectopic bone formation induced by purified bone morphogenetic protein. Int J Oral Maxillofac Surg 24 (1999) 143-150
22. Matin K., Nakamura H., Ire K., Ozawa H., and Ejiris S. Impact of recombinant human bone morphogenetic protein-2 on residual ridge resorption after tooth extraction: an experimental study in the rat. Int J Oral Maxillofac Implants 16 (2001) 400-411
23. Isobe M., Yamazaki Y., Mori M., and Amagasa T. Bone regeneration produced in rat femur defects by polymer capsules containing recombinant human bone morphogenetic protein-2. J Oral Maxillofac Surg 57 (1999) 695-698
24. Herford A.S., and Boyne P.J. Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg 66 (2008) 616-624